| Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection C Séror, MT Melki, F Subra, SQ Raza, M Bras, H Saïdi, R Nardacci, ... Journal of Experimental Medicine 208 (9), 1823-1834, 2011 | 210 | 2011 |
| Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In Vivo O Delelis, S Thierry, F Subra, F Simon, I Malet, C Alloui, S Sayon, ... Antimicrobial agents and chemotherapy 54 (1), 491-501, 2010 | 100 | 2010 |
| Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle S Munir, S Thierry, F Subra, E Deprez, O Delelis Retrovirology 10, 1-18, 2013 | 93 | 2013 |
| Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1β A Jaulmes, S Thierry, B Janvier, M Raymondjean, V Maréchal The FASEB journal 20 (10), 1727-1729, 2006 | 82 | 2006 |
| Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by diketo acid derivatives A Corona, FS Di Leva, S Thierry, L Pescatori, G Cuzzucoli Crucitti, ... Antimicrobial agents and chemotherapy 58 (10), 6101-6110, 2014 | 80 | 2014 |
| Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-κB, and c-Jun to the long … S Thierry, V Marechal, M Rosenzwajg, M Sabbah, G Redeuilh, JC Nicolas, ... Journal of virology 78 (22), 12198-12206, 2004 | 57 | 2004 |
| Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration S Thierry, S Munir, E Thierry, F Subra, H Leh, A Zamborlini, D Saenz, ... Retrovirology 12, 1-12, 2015 | 55 | 2015 |
| High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells S Thierry, J Gozlan, A Jaulmes, R Boniface, N Nasreddine, F Strauss, ... Aids 21 (3), 283-292, 2007 | 46 | 2007 |
| Stimulation of the Human RAD51 Nucleofilament Restricts HIV-1 Integration In Vitro and in Infected Cells O Cosnefroy, A Tocco, P Lesbats, S Thierry, C Calmels, T Wiktorowicz, ... Journal of virology 86 (1), 513-526, 2012 | 39 | 2012 |
| Drug-driven synthetic lethality: bypassing tumor cell genetics with a combination of AsiDNA and PARP inhibitors W Jdey, S Thierry, C Russo, F Devun, M Al Abo, P Noguiez-Hellin, JS Sun, ... Clinical Cancer Research 23 (4), 1001-1011, 2017 | 38 | 2017 |
| Micronuclei frequency in tumors is a predictive biomarker for genetic instability and sensitivity to the DNA repair inhibitor AsiDNA W Jdey, S Thierry, T Popova, MH Stern, M Dutreix Cancer research 77 (16), 4207-4216, 2017 | 32 | 2017 |
| Impact of the Ku complex on HIV-1 expression and latency G Manic, A Maurin-Marlin, F Laurent, I Vitale, S Thierry, O Delelis, ... PloS one 8 (7), e69691, 2013 | 25 | 2013 |
| Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase C Richetta, S Thierry, E Thierry, P Lesbats, D Lapaillerie, S Munir, F Subra, ... Journal of Biological Chemistry 294 (20), 8286-8295, 2019 | 21 | 2019 |
| Comparison between several integrase-defective lentiviral vectors reveals increased integration of an HIV vector bearing a D167H mutant MQ Saeed, N Dufour, C Bartholmae, U Sieranska, M Knopf, E Thierry, ... Molecular Therapy-Nucleic Acids 3, 2014 | 21 | 2014 |
| Preclinical studies comparing efficacy and toxicity of DNA repair inhibitors, olaparib, and AsiDNA, in the treatment of carboplatin-resistant tumors NI Herath, N Berthault, S Thierry, W Jdey, MC Lienafa, F Bono, ... Frontiers in Oncology 9, 1097, 2019 | 18 | 2019 |
| Opposite transcriptional regulation of integrated vs unintegrated HIV genomes by the NF-κB pathway S Thierry, E Thierry, F Subra, E Deprez, H Leh, S Bury-Moné, O Delelis Scientific reports 6 (1), 25678, 2016 | 16 | 2016 |
| Chromosomal tethering and proviral integration O Delelis, A Zamborlini, S Thierry, A Saïb Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1799 (3-4 …, 2010 | 16 | 2010 |
| The DNA repair inhibitor Dbait is specific for malignant hematologic cells in blood S Thierry, W Jdey, S Alculumbre, V Soumelis, P Noguiez-Hellin, M Dutreix Molecular Cancer Therapeutics 16 (12), 2817-2827, 2017 | 13 | 2017 |
| AsiDNA treatment induces cumulative antitumor efficacy with a low probability of acquired resistance W Jdey, M Kozlak, S Alekseev, S Thierry, P Lascaux, PM Girard, F Bono, ... Neoplasia 21 (9), 863-871, 2019 | 12 | 2019 |
| Dual and opposite effects of hRAD51 chemical modulation on HIV-1 integration S Thierry, MS Benleulmi, L Sinzelle, E Thierry, C Calmels, S Chaignepain, ... Chemistry & biology 22 (6), 712-723, 2015 | 12 | 2015 |
delelisCNRS確認したメール アドレス: lbpa.ens-cachan.fr